Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate, or extent of tolerance induction. [GOC:add]
Negative regulation of tolerance induction is a complex biological process that involves the modulation of immune responses to prevent excessive or inappropriate immune activation. Tolerance is a state of unresponsiveness to an antigen, and its induction is crucial for maintaining immune homeostasis and preventing autoimmune diseases. Here's a detailed breakdown of this process:
**1. Initial Antigen Encounter:** The process begins with the initial encounter of the immune system with an antigen. This antigen can be a foreign substance like a pathogen or a self-antigen that the immune system normally does not target.
**2. Antigen Presentation:** Specialized immune cells called antigen-presenting cells (APCs), like dendritic cells, engulf the antigen and process it. They then present fragments of the antigen on their surface using major histocompatibility complex (MHC) molecules.
**3. T Cell Activation and Differentiation:** The MHC-antigen complexes on APCs interact with T cell receptors (TCRs) on naive T cells. This interaction, along with co-stimulatory signals, activates the T cells and initiates their differentiation into specific subsets.
**4. Regulatory T Cell (Treg) Induction:** One crucial outcome of antigen presentation is the induction of regulatory T cells (Tregs). Tregs play a central role in suppressing immune responses. They are characterized by the expression of the transcription factor Foxp3 and the production of suppressive cytokines like IL-10 and TGF-β.
**5. Tolerance Induction Mechanisms:** Tregs suppress immune responses through various mechanisms:
* **Cytokine Suppression:** Tregs produce immunosuppressive cytokines that inhibit the activation and proliferation of effector T cells, such as IL-10 and TGF-β.
* **Direct Cell Contact:** Tregs can directly interact with effector T cells via cell surface molecules like CTLA-4, suppressing their activation and function.
* **Metabolic Modulation:** Tregs can modulate the metabolic environment of the immune microenvironment, creating conditions unfavorable for effector T cell activation.
**6. Prevention of Autoimmune Reactions:** The induction of tolerance by Tregs prevents autoimmune reactions. In the absence of Tregs, the immune system may mistakenly target self-antigens, leading to autoimmune diseases.
**7. Maintenance of Immune Homeostasis:** Negative regulation of tolerance induction ensures that immune responses are appropriately controlled, preventing excessive inflammation and maintaining immune homeostasis.
**8. Factors Influencing Tolerance Induction:** Various factors can influence tolerance induction, including:
* **Antigen Dose:** The dose and route of antigen exposure can influence the induction of tolerance.
* **Genetic Background:** Individual genetic predisposition can affect the efficiency of tolerance induction.
* **Environmental Factors:** Factors like stress, infection, and gut microbiota can impact immune regulation and tolerance.
In summary, negative regulation of tolerance induction is a complex process that involves the activation of regulatory T cells, which suppress immune responses and prevent excessive or inappropriate immune activation. This process is crucial for maintaining immune homeostasis and preventing autoimmune diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Programmed cell death protein 1 | A programmed cell death protein 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q15116] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
sesamin | (+)-sesamin : A lignan that consists of tetrahydro-1H,3H-furo[3,4-c]furan substituted by 1,3-benzodioxole groups at positions 1 and 4 (the 1S,3aR,4S,6aR stereoisomer). Isolated from Cinnamomum camphora, it exhibits cytotoxic activity. | benzodioxoles; furofuran; lignan | antineoplastic agent; neuroprotective agent; plant metabolite |
pomalidomide | 3-aminophthalimidoglutarimide: structure in first source | aromatic amine; dicarboximide; isoindoles; piperidones | angiogenesis inhibitor; antineoplastic agent; immunomodulator |
apiin | apiin : A beta-D-glucoside having a beta-D-apiosyl residue at the 2-position and a 5,4'-dihydroxyflavon-7-yl moiety at the anomeric position. apiin: structure | beta-D-glucoside; dihydroxyflavone; glycosyloxyflavone | EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; plant metabolite |
fosbretabulin | stilbenoid |